CREB5 Inhibits Neuronal Ferroptosis via Transactivating ApoL6 to Regulate Lipid Droplet Metabolism After Spinal Cord Injury
CNS Neuroscience & Therapeutics · 2026
DOI: 10.1002/cns.70783 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2026. Verfasst von Xiaolong Xi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Critical Care Medicine, Shaoxing People's Hospital, Shaoxing, Zhejiang, China. Hauptthemen laut MEDLINE: Spinal Cord Injuries, Neurons, Ferroptosis, Cyclic AMP Response Element-Binding Protein. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Science and Technology Project of Zhejiang Province.
Abstract (Originalsprache)
Background
After spinal cord injury (SCI), neuronal lipid peroxidation and excessive production of reactive oxygen species (ROS) induced by secondary injury exacerbate ferroptosis, impeding regenerative repair and functional recovery in mice. Thus, clarifying the molecular and cellular mechanisms underlying the inhibition of neuronal ferroptosis post‐SCI is crucial.
Methods
Single‐cell RNA sequencing (scRNA‐seq) and single‐cell assay for transposase‐accessible chromatin sequencing (scATAC‐seq) were used to analyze changes in the transcription factor CREB5 post‐SCI. Combined with in vitro (primary neuron experiments) and in vivo (mouse SCI model) studies, CREB5 was knocked down/overexpressed, and ApoL6 was overexpressed. Indicators related to neuronal ferroptosis (ROS, lipid peroxidation, free fatty acids, etc.) and functional recovery in mice were detected.
Results
After SCI, the transcriptional activity of the transcription factor CREB5 is enhanced, and its expression level first increases and then decreases. Mechanistically, CREB5 inhibits the decomposition of neuronal lipid droplets (LDs) by enhancing the transcriptional activity of the lipolysis‐related protein ApoL6, reducing the release of free fatty acids (FFA) and fatty acid oxidation (FAO), thereby decreasing ROS generation and lipid peroxidation, and ultimately inhibiting neuronal ferroptosis. In vitro experiments showed that CREB5 knockdown exacerbates neuronal death and inhibits axonal growth; in vivo experiments demonstrated that CREB5 knockdown hinders axonal growth and functional recovery in mice post‐SCI, while ApoL6 overexpression partially reverses these impairments.
Conclusions
CREB5 maintains the balance of neuronal lipid droplet metabolism by regulating ApoL6 and serves as a potential therapeutic target for inhibiting neuronal ferroptosis after SCI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgical Critical Care Medicine, Shaoxing People's Hospital, Shaoxing, Zhejiang, China.
- Department of Orthopedics, Shaoxing People's Hospital, Shaoxing, Zhejiang, China.
- Department of Surgical Critical Care Medicine, The First Affiliated Hospital, Shaoxing University, Shaoxing, Zhejiang, China.
Förderung
- Medical Science and Technology Project of Zhejiang Province
Zitieren
APA
Xi, X., Chen, Z., Wang, C., Wang, F., & Sun, X. (2026). CREB5 Inhibits Neuronal Ferroptosis via Transactivating ApoL6 to Regulate Lipid Droplet Metabolism After Spinal Cord Injury. CNS Neuroscience & Therapeutics. https://doi.org/10.1002/cns.70783
Vancouver
Xi X, Chen Z, Wang C, Wang F, Sun X. CREB5 Inhibits Neuronal Ferroptosis via Transactivating ApoL6 to Regulate Lipid Droplet Metabolism After Spinal Cord Injury. CNS Neuroscience & Therapeutics. 2026. doi:10.1002/cns.70783
BibTeX
@article{Xi2026,
author = {Xi, Xiaolong and Chen, Zhensen and Wang, Chaojun and Wang, Fei and Sun, Xuedong},
title = {CREB5 Inhibits Neuronal Ferroptosis via Transactivating ApoL6 to Regulate Lipid Droplet Metabolism After Spinal Cord Injury},
journal = {CNS Neuroscience & Therapeutics},
year = {2026},
doi = {10.1002/cns.70783}
}
EUVIMED